In his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance a...

In his role as the managing director, Singh will be responsible for driving the life science strategy in India, ensuring governance and com...

Merck has appointed Pratima Reddy as its country speaker for India. Reddy, who is currently the GM and managing director of Merck Specialit...

C3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, (known as MSD outside the US and Canada).

Processing special effect pigments, which is used to add glitter in cosmetics, fashion industry, apparels and paints, is still a major chal...

Going against the grain: With the unique hybrid model for India, co aims at building scale & ramping up businesses.

German pharmaceutical and life sciences company Merck has sold Bangalore GeNei, a firm that develops products for biological research, back...

The state government backed incubator T-Hub in Hyderabad will launch its first accelerator programme in health-tech in partnership with Mer...

Jubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.

Merck KGaA has decided to close down Bangalore GeNei, a company it had acquired in 2009 to bolster capabilities in design and production of...

"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...

The approvals are for Mycophenolate Mofetil in the strengths of 250 mg capsules and 500 mg tablets and Rizatriptan tablets in strengths of ...

The aim would be to continue the positive development of these activities in the future through further investment in growth, the statement...

Both the companies will jointly commercialise the compounds in the US market, and Merck will commercialise the deal in 150 countries, excep...

Emkay Global Financial Services has initiated ‘buy’ on Piramal Life Sciences for a target price of Rs 270.

Ranbaxy Laboratories has signed a strategic product development agreement with German pharma major Merck for drug discovery and clinical de...

Drug firm Merck Ltd today posted a net profit of Rs 15.93 crore for the first quarter ended March 31, 2007, as against Rs 18.54 crore for t...